Skip to main content
. Author manuscript; available in PMC: 2011 Sep 22.
Published in final edited form as: Cell Immunol. 2007 May 3;245(1):1–6. doi: 10.1016/j.cellimm.2007.03.006

Fig. 1.

Fig. 1

GlcN (A), but not Glc (B), reduces IL-2 production by Jurkat cells. Cells were activated with PHA in the presence of various doses of GlcN or Glc as indicated on the charts. Overnight incubations were performed. GlcN caused a dramatic reduction in IL-2 production by cells. However, the addition of GlcN or Glc did not affect the binding of Alexa-488-PHA to cells (C and D, respectively). (n=3)